Swiss Re Insurance-Linked Fund Management

PCS - Emerging Risks, New Opportunities

Minnesota Life returns for second La Vie Re mortality catastrophe bond

Share

Securian Financial Group life insurance subsidiary, Minnesota Life Insurance Company has returned to the insurance-linked securities (ILS) market to sponsor its second mortality catastrophe bond transaction, seeking another $100 million or more of capital markets backed extreme mortality reinsurance with a La Vie Re Limited (Series 2021-1) issuance.

reinsurance-contract-renewal-signingMinnesota Life Insurance Company sponsored its first mortality catastrophe bond arrangement in October 2020, securing $100 million of collateralized extreme mortality reinsurance protection from ILS investors through the La Vie Re Limited (Series 2020-1) deal.

This second La Vie Re mortality catastrophe bond, sees its sponsor seeking at least another $100 million of extreme mortality protection from the capital markets, on an indemnity stop loss basis, with reinsurance coverage triggered off its loss ratio.

Once again, Minnesota Life Insurance Company is looking to the insurance-linked securities (ILS) market to secure efficient stop loss mortality reinsurance coverage, with the help of structurer and bookrunner Willis Re Securities.

Using the same Bermuda based special purpose insurer, La Vie Re Limited, a single tranche of Series 2021-1 notes will be issued and sold to investors, with the proceeds used to collateralize mortality reinsurance agreements for the sponsor.

As in the previous deal, the SPI La Vie Re Limited will enter into an excess-of-loss reinsurance agreement with Securian Finacial’s captive reinsurer 1880 Reinsurance, which is based in Vermont.

1880 Reinsurance will then pass on the protection to ceding company Minnesota Life through the quota share reinsurance arrangements it enters into.

This cat bond will provide Minnesota Life with extreme mortality protection, on a loss ratio basis, so the collateral will be used to provide a stop loss type of reinsurance above a pre-defined loss ratio.

The notes will have a three-year term, running to the end of September 2024 and the risk period is based on loss ratios since October 1st this year, we’re told.

The notes trigger is described as an annual indemnity stop loss based on the sponsors loss ratio and for the covered business.

The $100 million of Series 2021-1 Class A notes being issued by La Vie Re Ltd. will have an initial expected loss of 0.19% on a modelled basis, we’re told, with the loss ratio attachment point set at 110%, which is the same trigger point as the first La Vie Re mortality cat bond.

Investors will be offered the Series 2021-1 Class A notes with price guidance in a range from 2.5% to 3%, which is the same guidance as the previous 2020-1 deal.

It’s encouraging to see Securian returning to the catastrophe bond market to extend and build-out its capital market backed excess mortality reinsurance protection with this second La Vie Re deal.

Mortality risk remains relatively scarce in the catastrophe bond market, so it’s good to see a fast-growing life insurer that considers integrating cat bonds within its reinsurance arrangements an efficient way to source risk capital to support that growth.

You can read all about this new La Vie Re Limited (Series 2021-1) mortality catastrophe bond and every other mortality linked or life ILS deal we have information on in our Artemis Deal Directory.

Artemis Live - ILS and reinsurance video interviews and podcastView all of our Artemis Live video interviews and subscribe to our podcast.

All of our Artemis Live insurance-linked securities (ILS), catastrophe bonds and reinsurance video content and video interviews can be accessed online.

Our Artemis Live podcast can be subscribed to using the typical podcast services providers, including Apple, Google, Spotify and more.

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.